Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Curative Biosciences
AddedFeb 20, 2024
UpdatedJun 18, 2026
Curative Biosciences

Curative Biosciences

Public

Curative Biosciences, a Miami-based medical firm, develops and markets novel CBD therapeutics across the US.

HQ
Miami, FL, US
Founded
2000
Overview
Compare
Employees

Curative Biosciences, a Miami-based medical firm, develops and markets novel CBD therapeutics across the US. Their product portfolio includes CBD oils, soft gels, and topicals. The company also conducts research on brain and nerve damage, diabetes, cancer, and rheumatoid arthritis.

Curative Biosciences has made significant strides in the CBD market, providing innovative solutions for various health conditions. Their impact is evident through their growing customer base and contributions to medical research.

Curative Biosciences - Similar Companies

Applied Biosciences logo

Applied Biosciences

curative ventures logo

curative ventures

Corix Bioscience logo

Corix Bioscience

Diverse Biotech logo

Diverse Biotech

CBD FLA logo

CBD FLA

CuraSen Therapeutics logo

CuraSen Therapeutics

curasen.com

Curio Wellness logo

Curio Wellness

curiowellness.com

Wellcana logo

Wellcana

Skye Bioscience logo

Skye Bioscience

Eureka Health logo

Eureka Health

eurekahealth.com

CuraleafHoldnc. logo

CuraleafHoldnc.

curaleaf.com

Canaria Therapeutics logo

Canaria Therapeutics

Out & About CBD logo

Out & About CBD

Emerald Health Pharmaceuticals logo

Emerald Health Pharmaceuticals

CBD Global Sciences logo

CBD Global Sciences

Curative Biosciences - Quick Facts

Who are Curative Biosciences' competitors?

Companies similar to Curative Biosciences include Applied Biosciences, curative ventures, Corix Bioscience and Diverse Biotech.

When was Curative Biosciences founded?

Curative Biosciences was founded in 2000.

Where is Curative Biosciences' headquarters located?

Curative Biosciences' headquarters is located in Miami, FL, US.

How many employees does Curative Biosciences have?

Curative Biosciences has 36 employees as of Feb 5, 2024.

Curative Biosciences - Classification

Industry
  • Retail
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
Main Product
  • CBD Products
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 2000Food And Kindred Products
  • 2090Miscellaneous Food Preparations And Kindred Products
Show 8 more industry codes
NAICS
  • 459900Other Miscellaneous Retailers
  • 459990All Other Miscellaneous Retailers
  • 459991Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers
  • 450000Retail Trade
  • 459000Sporting Goods, Hobby, Musical Instrument, Book, and Miscellaneous Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified